


文檔簡介
1、 HYPERLINK https:/www.MedChemE/Targets/SGK.html SGKSerum-glucocorticoid regulated kinase; Serum and glucocorticoid-regulated kinaseSerum- and glucocorticoid-inducible kinases (SGKs) form a novel family of serine/threonine kinases that are activated in responseto a variety of extracellular stimuli. S
2、GK family contains three isoforms: SGK1, SGK2, and SGK3. The mRNA encoding SGK1, thebest-studied member of the SGK family, is rapidly induced in response to a variety of stimuli, including growth factors, steroid andpeptide hormones, cytokines, changes in cell volume, and brain injury.SGKs are relat
3、ed to Akt (also called PKB), a serine/threonine kinase that plays a crucial role in promoting cell survival. The SGKfamily members share similar structure, substrate specificity and function with AKT and signal downstream of thephosphatidylinositol 3-kinase (PI3K) signalling pathway. They regulate a
4、 range of fundamental cellular processes such as cellproliferation and survival, thereby playing an important role in cancer development. In addition, SGKs not only regulate cellproliferation and survival, but also play important roles in cancer development via an AKT-independent signalling pathway.
5、 Theimportance of SGKs in cancer development and the scarcity of potent and selective SGK inhibitors support the urgent need fordiscovery and development of small molecules inhibitors targeting SGK for PIK3CA mutant cancers, and especially those that areresistant to AKT inhibition.www.MedChemE 1 HYP
6、ERLINK https:/www.MedChemE/Targets/SGK.html SGK HYPERLINK https:/www.MedChemE/Targets/SGK.html HYPERLINK https:/www.MedChemE/Targets/SGK.html Inhibitors HYPERLINK https:/www.MedChemE/cki7.html CKI-7 HYPERLINK https:/www.MedChemE/cki7.html HYPERLINK https:/www.MedChemE/cki-7.html CKI-7 HYPERLINK http
7、s:/www.MedChemE/cki-7.html HYPERLINK https:/www.MedChemE/cki-7.html free HYPERLINK https:/www.MedChemE/cki-7.html HYPERLINK https:/www.MedChemE/cki-7.html baseCat. No.: HY-W011109 Cat. No.: HY-133028CKI-7 is a potent and ATP-competitive casein kinase1 (CK1) ICinhibitor with an 50 of 6 M and a Kiof 8
8、.5 M. CKI-7 is a selective Cdc7 kinaseinhibitor. CKI-7 also inhibits SGK, ribosomalS6 kinase-1 (S6K1) and mitogen- andstress-activated protein kinase-1 (MSK1).CKI-7 free base is a potent and ATP-competitivecasein kinase 1 (CK1) inhibitor with an IC of 650M and a K of 8.5 M. CKI-7 free base is aisele
9、ctive Cdc7 kinase inhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.31%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/EMD638683.html EMD638683 HYPERLINK https:/www.MedChemE/EMD638683.html HYP
10、ERLINK https:/www.MedChemE/EMD638683-R-Form.html EMD638683 HYPERLINK https:/www.MedChemE/EMD638683-R-Form.html HYPERLINK https:/www.MedChemE/EMD638683-R-Form.html R-FormCat. No.: HY-15193 Cat. No.: HY-15193AEMD638683 is a highly selective SGK1 inhibitor,with an IC value of 3 M.50EMD638683 R-Form is
11、the R-form of EMD638683.EMD638683 is a highly selective SGK1 inhibitorwith IC of 3 M.50Purity: 99.80%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.68%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www
12、.MedChemE/EMD638683-S-Form.html EMD638683 HYPERLINK https:/www.MedChemE/EMD638683-S-Form.html HYPERLINK https:/www.MedChemE/EMD638683-S-Form.html S-Form HYPERLINK https:/www.MedChemE/EMD638683-S-Form.html HYPERLINK https:/www.MedChemE/GSK-650394.html GSK HYPERLINK https:/www.MedChemE/GSK-650394.html
13、 HYPERLINK https:/www.MedChemE/GSK-650394.html 650394Cat. No.: HY-15193B Cat. No.: HY-15192EMD638683 S-Form is the S-form of EMD638683.EMD638683 is a highly selective SGK1 inhibitorwith IC of 3 M.50GSK 650394 is a novel SGK inhibitor with IC of5062 nM and 103 nM for SGK1 and SGK2 in the SPAassay res
14、pectively. GSK 650394 also inhibitsinfluenza virus replication.Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.76%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/hu7691.html Hu7691 HYP
15、ERLINK https:/www.MedChemE/hu7691.html HYPERLINK https:/www.MedChemE/hu7691-free-base.html Hu7691 HYPERLINK https:/www.MedChemE/hu7691-free-base.html HYPERLINK https:/www.MedChemE/hu7691-free-base.html free HYPERLINK https:/www.MedChemE/hu7691-free-base.html HYPERLINK https:/www.MedChemE/hu7691-free
16、-base.html baseCat. No.: HY-132302 Cat. No.: HY-132302AHu7691 is an orally active, selective Aktinhibitor with IC s of 4.0 nM, 97.5 nM, 28 nM for50Akt1, Akt2 and Akt3, respectively. Hu7691 inhibitstumor growth and enables decrease of cutaneoustoxicity in mice.Hu7691 free base is an orally active, se
17、lectiveAkt inhibitor with IC s of 4.0 nM, 97.5 nM, 2850nM for Akt1, Akt2 and Akt3, respectively. Hu7691free base inhibits tumor growth and enablesdecrease of cutaneous toxicity in mice.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedS
18、ize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/pf-4950834.html PF-4950834 HYPERLINK https:/www.MedChemE/pf-4950834.html HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html PROTAC HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html
19、SGK3 HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html HYPERLINK https:/www.MedChemE/protac-sgk3-degrader-1.html degrader-1Cat. No.: HY-122011(SGK3-PROTAC1) Cat. No.: HY-125878PF-4950834 is a potent, selective, orallybioavailable, ATP-competitive rho kinase inhibitorwith IC values of 8.35 nM
20、 and 33.12 nM against50ROCK2 and ROCK1, respectively. PF-4950834 inhibitsneutrophil migration.PROTAC SGK3 degrader-1 (SGK3-PROTAC1), is a potentSKG3 degrader based on von Hippel-Lindau ligand.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.32%Clinical Data: No Development
21、 ReportedSize: 1 mg, 5 mg, 10 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/SGK1-IN-1.html SGK1-IN-1 HYPERLINK https:/www.MedChemE/SGK1-IN-1.html HYPERLINK https:/www.MedChemE/sgk1-in-2.html SGK1-IN-2Cat. No.: HY-18607 Cat. No.: HY-135893SGK1-IN-1 is a highly active and selectiveinhibitor of SGK-1, with an IC of 1 nM.50SGK1-IN-2 (14h) is a selective SGK1 (serum andglucocorticoid regulated kinase 1) inhibitor,with an IC of 5 nM at 10 M ATP concentration.50Purity: 98.76%Cli
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間,僅對用戶上傳內容的表現方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 中國房地產資金管理辦法
- 重慶保稅港區管理辦法
- 重慶水稻栽培管理辦法
- 帶嶺區娛樂設施管理辦法
- 2025屆云南省紅河縣一中物理高一下期末質量檢測模擬試題含解析
- 銀行崗位技能管理辦法
- 2025屆北京市第四十三中學物理高二第二學期期末達標檢測模擬試題含解析
- 金融風險預警管理辦法
- 銀行培訓管理辦法模板
- 瀘州公積金提取管理辦法
- 駐非洲員工管理制度
- 工程內業資料管理制度
- 美容院商業計劃書(完整版)
- 摩托車協議過戶協議書
- 2025年食品檢驗員考試試卷及答案
- 四川省德陽市2025年七年級下學期語文期末試卷及答案
- 黎族文化課件
- 中華人民共和國民營經濟促進法
- 色彩的魅力:藝術、科學與設計的交融
- 2025廣州市荔灣區輔警考試試卷真題
- 一季度安委會匯報材料
評論
0/150
提交評論